Ashland is a promising investment with a potential 58.3% upside, strong financials, and growth in biotechnology.

Ashland Inc. (NYSE:ASH – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Tuesday . The company ...

Ashland, Inc. is an additives and specialty ... personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and ...

Michael Sison, an analyst from Wells Fargo, maintained the Buy rating on Ashland (ASH – Research Report). The associated price target was ...

New Product Lines and Popular Brands Added to Meet Growing Demand for Quality Cannabis in Ashland ...

Ashland (NYSE:ASH – Free Report) had its target price upped by BMO Capital Markets from $83.00 to $84.00 in a research report released on Wednesday,Benzinga reports. BMO Capital Markets currently has ...